Published in Medicine and Law Weekly, March 11th, 2005
The panel gave the following recommendation: "It has potential application for fumigating rooms in clinical and pharmaceutical areas including areas containing complex electrical equipment. The product is rapidly microbicidal. Research and development has been completed and the product may have potential value; in use evaluations/trials are now needed in an NHS clinical setting."
Since submitting its information to the Rapid Review Panel last year, STERIS has conducted several...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.